While leading a pharmaceutical company, Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01) is also volunteering her expertise in the broader 9I制作厂免费 community and supporting students in realizing their leadership potential through the Samira Sakhia MBA Leadership Award.
Published on: 30 Aug 2021
Congratulations to Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01), who will take on a new challenge as President and Chief Executive Officer of Knight Therapeutics Inc., a Montreal-based company focused on acquiring or in-licensing and commercializing innovative pharmaceutical products for Canada and Latin America. Sakhia brings more than 20 years of leadership experience in the pharmaceutical industry to the role.听听听
Published on: 21 May 2021
Knight Therapeutics has announced the resignation of its chief financial officer, as the company鈥檚 president and Desautels International Faculty Advisory Board member, Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01), takes on the additional responsibility of CFO.
In doing so, Sakhia will leverage her 14 years of prior experience as CFO for Paladin Labs Inc.
Published on: 11 Oct 2017
At the Bloom Burton & Co Healthcare Investor Conference this May, Knight Therapeutics鈥� president, Samira Sakhia (BCom鈥�90, DPA鈥�94, MBA鈥�01) will be giving the Montreal-based specialty pharmaceutics company鈥檚 corporate update.
The event takes place at the Sheraton Centre Hotel at 11:30 on May 1. Those who won鈥檛 be at the event, but who are still interested in the presentation, can download a copy at the company鈥檚 website ().
Published on: 27 Apr 2017
In its 2016 financial results press release, Mississauga-based Profound Medical announced the appointment of Samira Sakhia (BCom鈥�90, MBA鈥�01) to its Board of Directors. Ms. Sakhia is also a member of the and serves as President of Knight Therapeutics. Prior to that, she was CFO of Paladin Labs, which she helped sell to Dublin-based pharma giant, Endo International.
Published on: 8 Mar 2017
Samira Sakhia, president of Knight Therapeutics, has joined听Crescita Therapeutics Inc.鈥檚听board of directors.听 Prior to her current role, she was the chief financial officer of Paladin Labs. She holds a Bachelor of Commerce degree in Finance and Accounting and a Masters of Business Administration in Strategy and Marketing from 9I制作厂免费 and is a Chartered Professional Accountant. Additionally,听Dr. Henrich Guntermann听and听Klaus von Lindeiner听have tendered their resignations as board members of the company.
Category:
Published on: 6 Oct 2016
Crescita Therapeutics Inc.听(Crescita or the Company), a commercial dermatology company with a portfolio of over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms, today announced that Samira Sakhia, President of Knight Therapeutics, has joined its board of directors. Prior to her current role, Ms. Sakhia was the Chief Financial Officer of Paladin Labs. Ms.
Category:
Published on: 30 Sep 2016
A monthly roundup of听 鈥榩eople on the move鈥� in Canada鈥檚 life science and biotech sectors.
...Samira Sakhia, former CFO of Paladin Labs Inc. , has joined the听Knight Therapeutics Inc.听team as president and as member of the company鈥檚 board of directors. Ms. Sakhia served as the CFO at Paladin (acquired by Endo International plc February 2014), from 2001 to 2015. She holds an MBA and a Bachelors of Commerce degree from 9I制作厂免费 and is also a Chartered Professional Accountant.
Category:
Published on: 13 Sep 2016
Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a leading Canadian specialty pharmaceutical company, today announced that Samira Sakhia, former CFO of Paladin Labs Inc. ("Paladin"), will be joining the Knight team as President and member of the Board of Directors. In her new role, beginning on August 31, 2016, Samira will report to Jonathan Ross Goodman, CEO of Knight.
Category:
Published on: 19 Aug 2016
Nuvo Research Inc. (TSX:NRI) (Nuvo or the Company), a specialty pharmaceutical company with growing revenues and a diverse portfolio of topical and immunology products, today announced the appointment of Samira Sakhia to its Board of Directors.听
Read full article: , November 3, 2015
听
Published on: 3 Nov 2015
